Hackensack Meridian Health, K Health roll out 24/7 primary care service: Incumbents like Hackensack Meridian are responding to patient expectations for convenient access to healthcare.
Senators target misleading drug ads on social media with new legislation: We examine the ramifications for marketers and ad agencies who are part of the health influencer economy.
23andMe’s board resigns: After years of ill-fated endeavors, the en masse resignation marks the latest blow to 23andMe, which has been hemorrhaging cash and yet to turn a profit.
Express Scripts sues the FTC: The pharmacy benefit manager is demanding the retraction of an agency report critical of pharma’s middlemen. Even if that happens, the damage to PBMs’ reputation is done.
Elevance, doctors quarrel over volume of Ozempic prescriptions: The insurer doesn’t want to cover Ozempic to treat obesity. But are healthcare providers the ones to blame?
Kourtney Kardashian’s Lemme rolls out “GLP-1” weight loss supplement: The move is ingenious from a marketing perspective. But the brand could find itself in drugmakers’ crosshairs with already confusing marketing about the supplement’s key ingredient.
Amazon adds Talkspace to digital health benefits program: The partnership dovetails with Talkspace’s push to reach more patients by partnering with health insurers and employers.
Most healthcare AI startups want to sell their solutions to health systems: But these tech companies struggle to demonstrate their value prop to potential healthcare provider buyers.
Health insurers’ use of AI tools linked to soaring claim denials: The claim denials process has become maddening for patients and providers alike.
More women than men skip out on medical care: Marketers should make more meaningful connections with female consumers, many of whom are the key healthcare decision-makers in their households.
Each patient generation takes a unique path on their health journey: We unpack the channels where patients begin their health journeys and explore how marketers can tailor their engagement strategies to best reach each generation.
Noom gets into compounded GLP-1s with a taper-off guarantee: It’s building a weight loss program around the idea that patients will eventually want to stop taking the medications. We explore the pros and cons.
FDA warns AbbVie for misleading TV ad ft. Serena Williams: Pharma marketers—particularly those who work with celebrities—ought to pay close attention to the regulator’s assertions.
The Surgeon General’s plan to protect kids, backed by state attorneys general, could change how platforms and advertisers engage users.
AI chatbots help busy healthcare providers communicate with patients: Consumers would rather engage with AI than wait on hold for a human. But many are concerned with the tech’s reliability and ability to protect their data.
Biden Administration’s final rules aim to boost mental healthcare parity law: But with no new enforcement mechanisms in place, we’re bearish on their ability to improve patients’ access to mental healthcare in a meaningful way.
Apple unveils new Apple Watch feature that detects sleep apnea: The timing of the feature’s unveiling could be the spark Apple needs to reignite its stagnating device business.
Ochsner expands its virtual weight management solution: The health system’s focus on selectively prescribing GLP-1s through affiliated physicians is a discerning financial move.
Global consumers are investing money to improve their health: There’s a market opportunity for brands and retailers across multiple sectors to reach consumers’ wallets via social media.
Senior-focused primary care orgs get patients to have more visits: While interesting, new findings from the Humana-led study should be taken with a grain of salt. The insurer has skin in the game with its CenterWell Senior Primary Care brand and clinics.